Clincosm LogoSign in Get a demo

Recurrent Melanoma

Showing 1 - 25 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Aerosol Sargramostim
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)

Active, not recruiting
Has Results
  • Acral Lentiginous Melanoma
  • +6 more
  • Mobile, Alabama
  • +190 more
Jan 28, 2023

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +848 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Washington, District of Columbia
  • +3 more
May 4, 2021

Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in Canada, United States

Active, not recruiting
Has Results
  • Melanoma of Unknown Primary
  • +4 more
  • Ipilimumab
  • Alfa Interferon
  • Birmingham, Alabama
  • +949 more
May 7, 2021

Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

Completed
Has Results
  • Adult Solid Tumor
  • +38 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Feb 18, 2021

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
Has Results
  • Malignant Melanoma
  • Recurrent Melanoma
  • (no location specified)
Oct 18, 2020

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, other, procedure)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Rochester, Minnesota
    Mayo Clinic
Sep 28, 2020

Recurrent Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma Trial in Buffalo (procedure, drug, other)

Completed
Has Results
  • Recurrent Melanoma
  • +9 more
  • Diagnostic Microscopy
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 24, 2020

Recurrent Melanoma, Stage IV Melanoma Trial in Los Angeles (Raf kinase inhibitor LGX818, binimetinib, laboratory biomarker

Withdrawn
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Raf kinase inhibitor LGX818
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 23, 2020

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Iris Melanoma
  • +19 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +147 more
Jun 24, 2020

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (aldesleukin, ipilimumab, laboratory

Completed
  • Recurrent Melanoma
  • +4 more
  • aldesleukin
  • +2 more
  • Maywood, Illinois
  • +4 more
Jun 17, 2020

Recurrent Melanoma, Stage IV Melanoma Trial in Philadelphia (CD40 agonist mAb CP-870,893, tremelimumab, laboratory biomarker

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • CD40 agonist monoclonal antibody CP-870,893
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Apr 6, 2020

Recurrent Melanoma, Stage IV Skin Melanoma Trial in Seattle (biological, other, radiation)

Terminated
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • Ipilimumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2020

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • cytology specimen collection procedure
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Dec 16, 2019

Recurrent Melanoma, Stage IV Skin Melanoma Trial in New York (Cisplatin, Gamma-Secretase Inhibitor RO4929097, Laboratory

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Skin Melanoma
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 24, 2019